The NAD+ biosynthetic pathway drives immunosuppression in high-grade serous ovarian cancer — ScienceD... - Verve Times

3/16/2022 12:00:00 AM3 years 1 month ago
by Addrew Shawn
by Addrew Shawn
High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases. The poor outcomes associated with the disease underscore the need for more effective treatments. A research team led by K
High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases. The poor outcomes associated with the disease underscore the need for … [+4783 chars]
full article...